期刊文献+

JNK信号通路在非酒精性脂肪肝病形成中的作用及其机制 被引量:10

Role of JNK signal transduction pathway in nonalcoholic fatty liver disease
原文传递
导出
摘要 目的观察c-Jun氨基末端激酶(JNK)信号传导通路在非酒精性脂肪肝病(NAFLD)大鼠中的表达,探讨其在NAFLD发病中的作用。方法雄性SD大鼠64只,随机分为8周对照组、12周对照组、8周高脂组及12周高脂组各16只,对照组喂饲普通饲料,高脂组喂饲高脂饲料。正糖高胰岛素钳夹实验技术检测葡萄糖输注率(GIR),生物化学法检测空腹血糖(FBS)、ALT、AST、甘油三酯(TG)、总胆固醇(TC);放射免疫法检测空腹胰岛素(Fins)、肿瘤坏死因子α(TNFα);分光光度计测定超氧化物歧化酶(SOD)、丙二醛(MDA)、游离脂肪酸(FFAs);Western blot检测肝组织JNK1、胰岛素受体底物1(IRS-1)、胰岛素受体底物1丝氨酸307磷酸化(pIRS-1^Ser307)、蛋白激酶B(PKB)、蛋白激酶B丝氨酸473磷酸化(P—PKB^Ser473)。正态分布数据采用t检验,偏态分布数据采用秩和检验。结果8周高脂组与8周对照组、12周高脂组与12周对照组比较:体质量、肝指数、血清ALT、AST、TG、TC、Fins、FFAs、TNFα、及肝匀浆TG、TC,FFAs、MDA,高脂组(8、12周)均明显高于对照组(8、12周),t值分别为5.90和7.92、9.91和7.42、5.49、4.99和5.31、7.37、2.30和5.86、2.64和3.85、3.86和6.61、10.53、7.07和8.45、T=89.5和T=100、5.20和6.18、11.90和17.83,P值均〈0.05或〈0.01。肝匀浆每毫克蛋白SOD:8周对照组、12周和8周高脂组、12周分别为(21.6±4.0)U、(22.0±3.6)U、(13.0±3.0)U、(10.1±2.2)U,高脂组明显降低,t值分别为4.88、7.92,P值均〈0.01;GIR:8周对照组、12周和8周高脂组、12周分别为(10.8±1.3)mg·kg^-1·min^-1、(10.7±1.2)mg·kg^-1·min^-1、(8.1±1.1)mg·kg^-1·min^-1、(6.3±1.5)mg·kg^-1·min^-1,高脂组明显降低,t值分别为4.52、6.41,P值均〈0.01;高脂组与同期对照组比较:肝组织JNK1蛋白表达、p—IRS-1^Ser307水平均增高,t值分别为4.39、5.81和4.06、6.48,P值均〈0.01,P—PKB^Ser473水平降低,t值分别为3.32、4.96,P值均〈0.01。JNK1的蛋白表达强度与IR呈正相关(Pearson相关系数为0.718,P〈0.01)。随着喂养时间的延长,高脂组大鼠肝细胞脂肪变性逐渐加重,8周形成NAFLD,12周可形成非酒精性脂肪性肝炎。结论高脂饮食可诱导肝组织JNK1增高,通过影响胰岛素信号蛋白IRS-1、PKB的磷酸化功能,导致IR从而参与了NAFLD的发生和发展。 Objective To investigate the role of c-Jun N-terminal kinase (JNK) signal transduction pathway in the rats of nonalcoholic fatty liver disease (NAFLD). Methods Sixty four Sprague-Dawley rats were randomly divided into four groups: 8-week control group (NGSw), 12-week control group (NG12 w), 8-week high-fat diet (HG8w), and 12-week high-fat diet group (HG12w), with 16 rats in each group. Glucose infusion rate (GIR) was tested by euglycemic hyperinsulinemic clamp;aminotransferase (ALT), aspartate aminotrans- ferase (AST), triglyceride (TG), total cholesterol (TC), free fatty acid (FFAs), fast insulin (Fins), tumor necrosis factor α (TNF α ), superoxide dismutase (SOD) and malondial- dehyde (MDA) were tested by biochemistry automatic analyzer or RIA; The expression of JNK 1, insulin receptor substrate-1 (IRS-1), phospho-IRS-1^Ser307 (p-IRS-1^ Ser307), Protien kinase B (PKB) and phospho-PKB^Ser473 (p- PKB^Ser473) were detected by Western blot. Results Compared to control group, body weight, liver index, serum levels of ALT, AST, TG, TC, Fins, FFAs, TNF α, and TC, TG FFAs, MDA in liver homogenates were increased, while the level of SOD, and GIR were decreased. The expression of JNK1 protein and p-IRS-1^Set307 in liver tissue was up-regulated, while expression of p-PKB^Ser473 was decreased (P 〈 0.05). A positive correlation was found between the expression intensity of JNK1 and IR (Pearson correlation: 0.718, P 〈 0.01). Conclusion The high-fat could induce the expression of JNKI, which in turn modulates the phosphorylation of proteins in the insulin signaling pathway, and induces insulin resistant.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2009年第11期821-825,共5页 Chinese Journal of Hepatology
基金 国家自然科学基金(30670945)
关键词 脂肪肝 胰岛素抗药性 大鼠 信号传导 C-JUN氨基末端激酶 Fatty liver Insulin resistance Rats Signal transduction C-Jun N-terminal kinase
  • 相关文献

参考文献10

  • 1Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology, 2005, 42: 987-1000.
  • 2张佳妮,陈金虎,谭莺,刘慧霞.吡格列酮对SD大鼠非酒精性脂肪肝病形成的预防作用及其机制[J].世界华人消化杂志,2009,17(8):758-764. 被引量:4
  • 3Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature, 2002, 420: 333-336.
  • 4Nguyen MT, Satoh H, Favelyukis S, et al. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem, 2005, 280:35361-35371.
  • 5Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1517
  • 6Kotronen A, Juurinen L, Hakkarainen A, et al. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care, 2008, 31: 165-169.
  • 7Leclercq IA, Da Silva Morais A, Schroyen B, et al. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol, 2007, 47: 142-156.
  • 8Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol, 2006, 7: 85-96.
  • 9Nakatani Y, Kaneto H, Kawamori D, et al. Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem, 2004, 279: 45803-45809.
  • 10Hotamisligil GS. Inflammation and metabolic disorders. Nature, 2006, 444: 860-867.

二级参考文献59

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Socha P, Wierzbicka A, Neuhoff-Murawska J, Wlodarek D, Podlesny J, Socha J. Nonalcoholic fatty liver disease as a feature of the metabolic syndrome.Rocz Panstw Zakl Hig 2007; 58:129-137.
  • 3Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 2008; 115:141-150.
  • 4Boppidi H, Daram SR. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome. Postgrad Med 2008; 120: E01-E07.
  • 5Khashab MA, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease as a component of the metabolic syndrome. Curr Gastroenterol Rep 2008; 10:73-80.
  • 6Hjelkrem MC, Tortes DM, Harrison SA. Nonalcoholic fatty liver disease. Minerva Med 2008; 99:583-593.
  • 7Abel T, Feher J. [Non-alcoholic fatty liver disease and cardiovascular risk] Orv Hetil 2008; 149: 1299-1305.
  • 8Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 2005; 50: 171-180.
  • 9Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004.; 279:32345-32353.
  • 10Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37:1202-1219.

共引文献1518

同被引文献46

引证文献10

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部